Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 02 Jan 2024 18:00 CET |
EQUASENS | EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 02 Jan 2024 18:00 CET |
EQUASENS | Equasens: Acquisition of a majority stake in DIGIPHARMACIE | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 27 Dec 2023 18:00 CET |
EQUASENS | EQUASENS : Evolution du Comité de Direction du Groupe Equasens | 10101015 Software | Journal / appointments |
| 27 Dec 2023 18:00 CET |
EQUASENS | Equasens: Changes in the Equasens Group Executive Committee | 10101015 Software | Journal / appointments |
| 23 Nov 2023 18:00 CET |
EQUASENS | EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 23 Nov 2023 18:00 CET |
EQUASENS | EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 09 Nov 2023 18:00 CET |
EQUASENS | EQUASENS : Chiffre d’affaires du 3ème trimestre 2023 | 10101015 Software | Sales |
| 09 Nov 2023 18:00 CET |
EQUASENS | Equasens: Q3 2023 revenue | 10101015 Software | Sales |
| 04 Oct 2023 18:06 CEST |
EQUASENS | EQUASENS : Mise à disposition du Rapport Financier Semestriel 2023 | 10101015 Software | Income |
| 29 Sep 2023 18:00 CEST |
EQUASENS | EQUASENS: H1 2023 Results | 10101015 Software | Income |
| 29 Sep 2023 18:00 CEST |
EQUASENS | EQUASENS : Résultats Semestriels 2023 | 10101015 Software | Income |
| 25 Sep 2023 18:00 CEST |
EQUASENS | EQUASENS : bilan du contrat de liquidité au 30 juin 2023 | 10101015 Software | Other subject |
| 03 Aug 2023 18:00 CEST |
EQUASENS | GROUPE EQUASENS : Chiffre d’affaires du 1er semestre 2023 en progression de 9 % à 112,62 M€ | 10101015 Software | Sales |
| 03 Aug 2023 18:00 CEST |
EQUASENS | EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m | 10101015 Software | Sales |
| 05 Jul 2023 18:00 CEST |
EQUASENS | EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023 | 10101015 Software | General meeting / Board Meeting |
| 05 Jul 2023 18:00 CEST |
EQUASENS | EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023 | 10101015 Software | General meeting / Board Meeting |
| 09 Jun 2023 18:00 CEST |
EQUASENS | EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES | 10101015 Software | General meeting / Board Meeting |
| 09 Jun 2023 18:00 CEST |
EQUASENS | EQUASENS: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS | 10101015 Software | General meeting / Board Meeting |
| 11 May 2023 18:00 CEST |
EQUASENS | EQUASENS: Q1 2023 revenue: +13.96% to €56.25m | 10101015 Software | Sales |
| 11 May 2023 18:00 CEST |
EQUASENS | EQUASENS : Chiffre d’affaires T1 2023 : +13,96% à 56,25 M€ | 10101015 Software | Sales |
| 04 May 2023 12:00 CEST |
EQUASENS | EQUASENS : Mise à disposition du Document d’Enregistrement Universel 2022 | 10101015 Software | Other subject |
| 06 Apr 2023 18:00 CEST |
EQUASENS | EQUASENS : Atoopharm, le spécialiste e-learning de la formation officinale, rejoint le Groupe Equasens. | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 03 Apr 2023 07:00 CEST |
EQUASENS | EQUASENS : Acquisitions de Pratilog et Speech2Sense | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 24 Mar 2023 18:00 CET |
EQUASENS | EQUASENS : Résultat Net 2022 : +18,35% à 48,70 M€ | 10101015 Software | Income |
| 24 Mar 2023 18:00 CET |
EQUASENS | EQUASENS: 2022 Net Profit: +18.35% to €48.70m | 10101015 Software | Income |
| 03 Feb 2023 18:00 CET |
EQUASENS | EQUASENS : CA 2022 : +10,88% à 214,07 M€ | 10101015 Software | Sales |
| 03 Feb 2023 18:00 CET |
EQUASENS | EQUASENS: FY 2022 revenue: +10.88% to €214.07m | 10101015 Software | Sales |
| 20 Jan 2023 18:00 CET |
EQUASENS | EQUASENS : BILAN SEMESTRIEL S2-2022 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC GILBERT DUPONT | 10101015 Software | Share history |
| 20 Jan 2023 18:00 CET |
EQUASENS | EQUASENS: H2 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT | 10101015 Software | Share history |
| 19 Jan 2023 18:00 CET |
EQUASENS | EQUASENS : Nomination de Frédérique SCHMIDT en tant que Directrice Administrative et Financière du Groupe | 10101015 Software | Journal / appointments |
| 19 Jan 2023 18:00 CET |
EQUASENS | EQUASENS: Appointment of Frédérique SCHMIDT as the Group’s Chief Administrative and Financial Officer | 10101015 Software | Journal / appointments |